A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas
By Ph.D B. WAYNE BEQUETTE. 2005
278 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Endocrinology, Diabetes and Metabolism, Surgery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- Nicholas A. Peppas
- Robert Langer
- Ernesto C. Martínez
- Mariano De Paula
- Terry G. Farmer
- Thomas F. Edgar
- Gerardo Gabriel Acosta
- Ali Khademhosseini
In Endocrinology, Diabetes and Metabolism
- Peter Diem
- Stavroula G. Mougiakakou
- Ernesto C. Martínez
- Mariano De Paula
- Gerardo Gabriel Acosta
- Elena Daskalaki
- Boris P. Kovatchev
- Eric Renard
In Surgery
- Ernesto C. Martínez
- Mariano De Paula
- Gerardo Gabriel Acosta
- Peter Diem
- Stavroula G. Mougiakakou
- Elena Daskalaki
- Boris P. Kovatchev
- Eric Renard
Citations in the corpus
- Artificial Pancreas: Past, Present, Future (2011, background): “, overnight), and postprandial regulation calling for prompt and energetic corrections (102,103).”
- On-line policy learning and adaptation for real-time personalization of an artificial pancreas (2015, methodology): “The well known proportional–integrative–derivative feedback controller was employed as an early close-loop control algorithm for the AP (Bequette, 2005).”
- Application of Micro- and Nano-Electromechanical Devices to Drug Delivery (2006, background): “The continuous glucose monitoring field, in particular, has developed a number of algorithms to translate raw data from glucose sensors into alerts for impending hypoglycemia, although the ultimate goal of an implantable closed-loop system with automatic control of insulin delivery has not been real”
- The future of open‐ and closed‐loop insulin delivery systems (2008, methodology): “An argument against the use of PID controllers to mimic the biphasic insulin profile is made by Bequette (2005), who argues that such a response can be the result of any control system in which integral action is present, and that internal model controllers can also have the same response.”
- An Actor-Critic based controller for glucose regulation in type 1 diabetes (2013, background): “and = [ 1 2] is the Actor’s parameter vector.”